Clinical Trials Logo

Crow's Feet Lines clinical trials

View clinical trials related to Crow's Feet Lines.

Filter by:

NCT ID: NCT01797081 Completed - Crow's Feet Lines Clinical Trials

BOTOX® in the Treatment of Crow's Feet Lines in Japan

Start date: January 31, 2013
Phase: Phase 3
Study type: Interventional

This study will evaluate the safety and efficacy of BOTOX® (botulinum toxin Type A) compared to placebo for the treatment of Crow's Feet Lines (Lateral Canthus Rhytides).

NCT ID: NCT01224015 Completed - Glabellar Lines Clinical Trials

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines

Start date: May 2011
Phase: Phase 3
Study type: Interventional

This study will evaluate the safety and efficacy of botulinum toxin type A compared to placebo for the treatment of Crow's Feet Lines and Frown Lines (Facial Rhytides) for patients who successfully completed Study 191622-099.

NCT ID: NCT01189760 Completed - Glabellar Lines Clinical Trials

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines

Start date: September 1, 2010
Phase: Phase 3
Study type: Interventional

This study will evaluate the safety and efficacy of botulinum toxin Type A compared to placebo for the treatment of Crow's Feet Lines and Frown Lines (Facial Rhytides)

NCT ID: NCT01189747 Completed - Crow's Feet Lines Clinical Trials

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines

Start date: October 1, 2010
Phase: Phase 3
Study type: Interventional

This study will evaluate the safety and efficacy of botulinum toxin Type A compared to placebo for the treatment of Crow's Feet Lines (Lateral Canthal Rhytides).